No Data
Tryptamine Therapeutics Strengthens Scientific Advisory Board With Eating Disorder Expert
Tryptamine Therapeutics Doses First Patient in Irritable Bowel Syndrome Study
Tryptamine Therapeutics Doses First Patient in IBS Clinical Study at Massachusetts General Hospital
Tryptamine Therapeutics Concludes Phase 2a Clinical Study for Pain and Tenderness Drug; Shares Rise 11%
Tryptamine Therapeutics Achieves Milestone of World's First IV-infused Psilocin Dosing
Tryptamine Therapeutics Completes Maiden Dosing of IV Psilocin – a Global First
No Data
